Atlas Trials

Dose Ranging Study Comparing the Efficacy, Safety and Pharmacokinetics of Intravenous Infusions of ABT-874 vs Placebo in Subjects With Active Crohn's Disease

Clinical trial NCT00562887 · TERMINATED

Trial details

NCT number
NCT00562887
Sponsor
Abbott
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Crohn's Disease
Start date
2007-11-01
Primary completion
2010-04-01
Enrollment
246

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.